Infinia ML
Infinia ML is Aspirion's dedicated AI team, building ClaimIQ—a production AI platform for healthcare revenue cycle management that automates denials management, appeals processing, and underpayment recovery for the nation's largest hospital systems.
- Company typePrivate
- Founded2017
- HeadquartersDurham, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Infinia ML does
Infinia ML is a private healthcare AI company that builds production-grade machine learning systems for revenue cycle management (RCM). Founded in 2017 as a spin-out from Duke University's research labs and acquired by Aspirion in 2023, the company operates as Aspirion's dedicated AI team, serving the nation's largest health systems with denials management, appeals processing, and underpayment recovery workflows.
The company's core product is ClaimIQ, a unified AI platform comprising three integrated sub-products: DocIQ for multi-modal document extraction (reading UB-04s, interpreting medical records, and generating evidence-based appeal letters), ContractIQ for payer contract intelligence (parsing contracts and addenda into structured rule databases and calculating expected reimbursement), and ClinIQ for clinical evidence analysis and denial pattern intelligence. The platform is built on novel retrieval-augmented generation (RAG) architectures and multi-agent systems engineered for enterprise scale where errors carry real financial consequences. Reported performance includes 99.7% document extraction accuracy, 2.2x faster first-appeal filing, 50,000+ documents processed monthly, and a 20%+ lift in claims overturn rates compared to manual review.
Infinia ML generates revenue through enterprise sales of healthcare RCM AI services, distributed exclusively through Aspirion's existing relationships with large hospital systems in the United States. Pricing is not publicly disclosed and is negotiated per client contract under a subscription/recurring model. The company is headquartered in Durham, NC, with a distributed team of 35+ machine learning researchers and AI engineers. Following the 2023 acquisition, Infinia ML functions as Aspirion's R&D engine rather than operating as a standalone commercial entity.
Infinia ML firmographics
Firmographics- Name
- Infinia ML
- Legal name
- Infinia ML, Inc.
- Website
- https://infiniaml.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Infinia ML is Aspirion's dedicated AI team, building ClaimIQ—a production AI platform for healthcare revenue cycle management that automates denials management, appeals processing, and underpayment recovery for the nation's largest hospital systems.
- Ownership category
- akta.pro rank
Infinia ML industry classification
Industry- Product category
- Healthcare Revenue Cycle Management AI
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Claims Management, Scrubbing & Clearinghouse (HLACACAB)
- akta.pro secondary industries
- Price Transparency, Estimates & Patient Financial Clearance (HLACACAK), Claims Administration & Payment Integrity (Medical/Dental/Vision) (HLAEALAD), Claims Data Capture, Indexing & Document Management (BPAAAFAB)
Keywords
Where Infinia ML is headquartered
LocationHeadquarters
- HQ city
- Durham
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Infinia ML business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
Revenue model
- Healthcare RCM AI Platform Services: Infinia ML provides AI-powered revenue cycle management services to hospitals and health systems through Aspirion's operations. The company generates revenue by delivering measurable results including faster appeals, higher claims overturn rates, and document processing at scale.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Infinia ML product offering
Product offeringCore offering
Infinia ML builds and operates ClaimIQ, a unified AI platform for healthcare revenue cycle management, deployed through Aspirion to the nation's largest health systems. The platform automates clinical document extraction, payer contract interpretation, and evidence-based appeal generation, processing 50,000+ documents monthly with 99.7% accuracy to overturn denied and underpaid claims at enterprise scale.
Product overview
Infinia ML is Aspirion's dedicated AI team, offering ClaimIQ—a unified AI platform for healthcare revenue cycle management. ClaimIQ consists of three integrated sub-products: DocIQ for complex document extraction and appeal generation, ContractIQ for payer contract intelligence and reimbursement calculation, and ClinIQ for clinical evidence analysis and denial pattern intelligence. These three integrated platforms work as one to solve denials and underpayment challenges at enterprise scale.
Differentiator
Problem solved
Functional benefit
Brands
- ClaimIQ: A unified AI platform for healthcare revenue cycle management, consisting of three integrated platforms: DocIQ (clinical document extraction and appeal generation), ContractIQ (payer contract intelligence), and ClinIQ (clinical evidence analysis).
- DocIQ
- ContractIQ
- ClinIQ
Products and services
- ClaimIQ A unified AI platform for healthcare revenue cycle management that brings together document intelligence, contract analysis, and clinical evidence review into a single integrated workflow, deployed across the nation's largest health systems.
- DocIQ An AI-powered appeals workbench that reads UB-04 billing forms, interprets medical records, and generates tailored, evidence-based appeal letters grounded in clinical guidelines, payer policies, and regulations, for hospitals and health systems managing denied claims.
- ContractIQ A payer contract intelligence platform that parses payer contracts and addenda into structured, queryable rule databases and calculates expected reimbursement by combining claim data with Medicare fee schedules, CMS weight tables, and other payer-specific sources.
- ClinIQ A clinical evidence analysis platform that analyzes the clinical evidence behind each claim to assess case strength, transforms denial outcomes into structured actionable insights, and surfaces documentation weaknesses and denial patterns across a health system's full claims portfolio.
Quantifiable outcome
- 2.2x faster first appeals filed before deadlines or opportunities close
- +4 more outcomes
Companies that use Infinia ML
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
Infinia ML technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability10 records
Feature5 records
Infinia ML partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- AspirioncoreInfinia ML is Aspirion's dedicated AI team, acquired by Aspirion in 2023. Aspirion is a revenue cycle management company serving hospitals and health systems. Infinia ML was spun out of Duke University's research labs in 2017 and serves as Aspirion's research and development engine for AI solutions.
Scale indicators5 records
Recent moves7 records
Expansion highlights4 records
Infinia ML competitors and assessment
Company assessmentDirect peers
- SmarterDx: AI-native clinical documentation and revenue integrity platform for hospitals, focused on capturing missed diagnoses and revenue opportunities — a direct competitor in the AI-for-healthcare-RCM category serving large health systems.
- Olive AI: Healthcare-focused AI company building automation for revenue cycle workflows including denials and prior authorization; competes with Infinia for AI-native RCM deployments at large provider systems.
- AKASA: AI platform purpose-built for healthcare revenue cycle operations, including denials management and claims status — overlapping directly with Infinia's ClaimIQ use cases at hospitals and health systems.
- CodaMetrix: AI-powered medical coding and clinical documentation platform for hospitals, using ML on unstructured clinical text — directly comparable to Infinia's DocIQ and ClinIQ in the AI-for-RCM space.
- Anterior: AI platform for prior authorization and clinical review, applying LLMs to payer-provider workflows — an emerging AI-native peer adjacent to Infinia's denials and appeals focus.
Broad incumbents
- Waystar: Large, established RCM software platform covering claims management, denials, and patient payments; competes with Infinia in the denials/underpayment workflow but as part of a much broader end-to-end suite.
- R1 RCM: Major technology-enabled RCM services company serving large hospital systems; competes with Aspirion/Infinia for outsourced RCM engagements and increasingly for AI-native RCM technology.
- Optum (UnitedHealth Group): Largest healthcare services and technology platform, including Optum Insight RCM offerings; a broad incumbent competing for the same health system RCM and AI budgets that Infinia targets.
Emerging players
- Cohere Health: AI-driven prior authorization and clinical review platform for health plans and providers — an emerging player with partial overlap in clinical-evidence-driven denial and approval workflows.
- Maverick Medical AI: AI platform for medical coding and RCM documentation, focused on autonomous coding from clinical notes — an emerging AI-native peer adjacent to Infinia's document and evidence analysis capabilities.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Infinia ML social profiles
Digital presenceInfinia ML financial estimates
Financial estimateRevenue estimate
Valuation estimate
Infinia ML leadership team
Management profileNumber of profiles
Profiles6 records
Infinia ML funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Infinia ML M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Infinia ML
What does Infinia ML do?
Infinia ML builds and operates ClaimIQ, a unified AI platform for healthcare revenue cycle management, deployed through Aspirion to the nation's largest health systems. The platform automates clinical document extraction, payer contract interpretation, and evidence-based appeal generation, processing 50,000+ documents monthly with 99.7% accuracy to overturn denied and underpaid claims at enterprise scale.
Is Infinia ML a public or private company?
Infinia ML is a private company. It is classified as corporate owned and is currently operating.
When was Infinia ML founded?
Infinia ML was founded in 2017. It employs 11 to 50 people.
Where is Infinia ML based?
Infinia ML is headquartered in Durham, United States, in the North America region.
How does Infinia ML make money?
One revenue line is on record: healthcare RCM AI Platform Services.
Who are Infinia ML's main competitors?
Direct peers on record are SmarterDx, Olive AI, AKASA, CodaMetrix and Anterior. Broad incumbents are Waystar, R1 RCM and Optum (UnitedHealth Group). Emerging players are Cohere Health and Maverick Medical AI.
Does Infinia ML have an API?
No public API is recorded for Infinia ML.
What industry is Infinia ML in?
Infinia ML's product category is Healthcare Revenue Cycle Management AI. Its primary akta.pro industry code is HLACACAB, Claims Management, Scrubbing & Clearinghouse, with a secondary code of HLACACAK, Price Transparency, Estimates & Patient Financial Clearance. Its NAICS code is 5132 and its SIC code is 7372.